Cryoport (CYRX) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Cryoport Revenues Climb 74% for the Second Quarter of Fiscal Year 2016
November 16, 2015 8:02 AM ESTLAKE FOREST, Calif., Nov. 16, 2015 /PRNewswire/ --Â Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company") today announced financial results for the three and six month periods ended September 30, 2015.
Commenting on the second quarter results, Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "We delivered strong top line growth of 74%, overcoming seasonality and orders that slipped to our third fiscal quarter. This growth was driven by the addition of a significant number of new clients, as well as continuing growth within our existing client base. Given our traction and client... More
